nodes	percent_of_prediction	percent_of_DWPC	metapath
Isoniazid—CYP1A2—Imiquimod—skin cancer	0.104	0.116	CbGbCtD
Isoniazid—CYP2C8—Vismodegib—skin cancer	0.0933	0.104	CbGbCtD
Isoniazid—CYP2C19—Vismodegib—skin cancer	0.0783	0.0869	CbGbCtD
Isoniazid—CYP2E1—Dacarbazine—skin cancer	0.0757	0.084	CbGbCtD
Isoniazid—CYP2A6—Fluorouracil—skin cancer	0.0672	0.0746	CbGbCtD
Isoniazid—CYP2C9—Vismodegib—skin cancer	0.0651	0.0723	CbGbCtD
Isoniazid—CYP1A2—Vemurafenib—skin cancer	0.0571	0.0634	CbGbCtD
Isoniazid—CYP3A4—Temozolomide—skin cancer	0.0546	0.0606	CbGbCtD
Isoniazid—CYP3A4—Imiquimod—skin cancer	0.0546	0.0606	CbGbCtD
Isoniazid—CYP2D6—Vemurafenib—skin cancer	0.047	0.0522	CbGbCtD
Isoniazid—CYP1A2—Dacarbazine—skin cancer	0.0438	0.0486	CbGbCtD
Isoniazid—CYP3A4—Vismodegib—skin cancer	0.0378	0.042	CbGbCtD
Isoniazid—CYP2C8—Fluorouracil—skin cancer	0.0331	0.0368	CbGbCtD
Isoniazid—CYP3A4—Vemurafenib—skin cancer	0.0299	0.0332	CbGbCtD
Isoniazid—CYP1A2—Fluorouracil—skin cancer	0.0257	0.0285	CbGbCtD
Isoniazid—CYP2C9—Fluorouracil—skin cancer	0.0231	0.0257	CbGbCtD
Isoniazid—CYP3A4—Docetaxel—skin cancer	0.0103	0.0114	CbGbCtD
Isoniazid—Emotional distress—Fluorouracil—skin cancer	0.00293	0.0294	CcSEcCtD
Isoniazid—Vasculitis—Vemurafenib—skin cancer	0.00271	0.0272	CcSEcCtD
Isoniazid—Reaction gastrointestinal—Docetaxel—skin cancer	0.00269	0.027	CcSEcCtD
Isoniazid—Eruption—Dactinomycin—skin cancer	0.00243	0.0244	CcSEcCtD
Isoniazid—Neurotoxicity—Docetaxel—skin cancer	0.00232	0.0233	CcSEcCtD
Isoniazid—Lymphadenopathy—Imiquimod—skin cancer	0.00192	0.0192	CcSEcCtD
Isoniazid—Hepatic function abnormal—Imiquimod—skin cancer	0.00187	0.0188	CcSEcCtD
Isoniazid—Memory impairment—Temozolomide—skin cancer	0.00172	0.0173	CcSEcCtD
Isoniazid—Eosinophilia—Vemurafenib—skin cancer	0.00164	0.0165	CcSEcCtD
Isoniazid—Systemic lupus erythematosus—Docetaxel—skin cancer	0.00162	0.0163	CcSEcCtD
Isoniazid—Liver injury—Temozolomide—skin cancer	0.00161	0.0161	CcSEcCtD
Isoniazid—Hyperbilirubinaemia—Temozolomide—skin cancer	0.00149	0.0149	CcSEcCtD
Isoniazid—Eruption—Docetaxel—skin cancer	0.00146	0.0147	CcSEcCtD
Isoniazid—Neuropathy peripheral—Vemurafenib—skin cancer	0.00145	0.0145	CcSEcCtD
Isoniazid—Aplastic anaemia—Dactinomycin—skin cancer	0.0014	0.0141	CcSEcCtD
Isoniazid—Dyspepsia—Vismodegib—skin cancer	0.00134	0.0135	CcSEcCtD
Isoniazid—Decreased appetite—Vismodegib—skin cancer	0.00133	0.0133	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Vismodegib—skin cancer	0.00132	0.0132	CcSEcCtD
Isoniazid—Fatigue—Vismodegib—skin cancer	0.00132	0.0132	CcSEcCtD
Isoniazid—Aplastic anaemia—Temozolomide—skin cancer	0.00127	0.0127	CcSEcCtD
Isoniazid—Neuropathy peripheral—Imiquimod—skin cancer	0.00124	0.0124	CcSEcCtD
Isoniazid—Neuritis—Docetaxel—skin cancer	0.0012	0.0121	CcSEcCtD
Isoniazid—Asthenia—Vismodegib—skin cancer	0.0011	0.011	CcSEcCtD
Isoniazid—Hyperbilirubinaemia—Docetaxel—skin cancer	0.000988	0.00991	CcSEcCtD
Isoniazid—Vomiting—Vismodegib—skin cancer	0.000971	0.00974	CcSEcCtD
Isoniazid—Rash—Vismodegib—skin cancer	0.000963	0.00966	CcSEcCtD
Isoniazid—Ill-defined disorder—Imiquimod—skin cancer	0.000915	0.00918	CcSEcCtD
Isoniazid—Nausea—Vismodegib—skin cancer	0.000907	0.0091	CcSEcCtD
Isoniazid—Hepatocellular injury—Docetaxel—skin cancer	0.000899	0.00902	CcSEcCtD
Isoniazid—Malaise—Imiquimod—skin cancer	0.000889	0.00892	CcSEcCtD
Isoniazid—Convulsion—Imiquimod—skin cancer	0.000854	0.00857	CcSEcCtD
Isoniazid—Discomfort—Imiquimod—skin cancer	0.000829	0.00832	CcSEcCtD
Isoniazid—Decreased appetite—Vemurafenib—skin cancer	0.00082	0.00823	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Vemurafenib—skin cancer	0.000815	0.00817	CcSEcCtD
Isoniazid—Fatigue—Vemurafenib—skin cancer	0.000813	0.00816	CcSEcCtD
Isoniazid—Agranulocytosis—Dactinomycin—skin cancer	0.00078	0.00782	CcSEcCtD
Isoniazid—Eosinophilia—Fluorouracil—skin cancer	0.000774	0.00776	CcSEcCtD
Isoniazid—Anorexia—Imiquimod—skin cancer	0.000767	0.00769	CcSEcCtD
Isoniazid—Hyperglycaemia—Temozolomide—skin cancer	0.000765	0.00767	CcSEcCtD
Isoniazid—Hepatitis—Dactinomycin—skin cancer	0.00075	0.00753	CcSEcCtD
Isoniazid—Body temperature increased—Vemurafenib—skin cancer	0.000746	0.00748	CcSEcCtD
Isoniazid—Neuropathy peripheral—Temozolomide—skin cancer	0.000741	0.00743	CcSEcCtD
Isoniazid—Paraesthesia—Imiquimod—skin cancer	0.000723	0.00725	CcSEcCtD
Isoniazid—Dyspepsia—Imiquimod—skin cancer	0.000708	0.0071	CcSEcCtD
Isoniazid—Decreased appetite—Imiquimod—skin cancer	0.000699	0.00702	CcSEcCtD
Isoniazid—Hypersensitivity—Vemurafenib—skin cancer	0.000695	0.00697	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Imiquimod—skin cancer	0.000695	0.00697	CcSEcCtD
Isoniazid—Fatigue—Imiquimod—skin cancer	0.000694	0.00696	CcSEcCtD
Isoniazid—Neuropathy peripheral—Fluorouracil—skin cancer	0.000683	0.00685	CcSEcCtD
Isoniazid—Hepatitis—Temozolomide—skin cancer	0.000679	0.00681	CcSEcCtD
Isoniazid—Asthenia—Vemurafenib—skin cancer	0.000677	0.00679	CcSEcCtD
Isoniazid—Feeling abnormal—Imiquimod—skin cancer	0.000663	0.00665	CcSEcCtD
Isoniazid—Agranulocytosis—Fluorouracil—skin cancer	0.00065	0.00652	CcSEcCtD
Isoniazid—Ill-defined disorder—Bleomycin—skin cancer	0.00065	0.00652	CcSEcCtD
Isoniazid—Body temperature increased—Imiquimod—skin cancer	0.000636	0.00638	CcSEcCtD
Isoniazid—Malaise—Bleomycin—skin cancer	0.000632	0.00634	CcSEcCtD
Isoniazid—Ill-defined disorder—Dactinomycin—skin cancer	0.000606	0.00608	CcSEcCtD
Isoniazid—Vomiting—Vemurafenib—skin cancer	0.0006	0.00602	CcSEcCtD
Isoniazid—Rash—Vemurafenib—skin cancer	0.000595	0.00597	CcSEcCtD
Isoniazid—Hypersensitivity—Imiquimod—skin cancer	0.000593	0.00595	CcSEcCtD
Isoniazid—Discomfort—Bleomycin—skin cancer	0.000589	0.00591	CcSEcCtD
Isoniazid—Malaise—Dactinomycin—skin cancer	0.000589	0.00591	CcSEcCtD
Isoniazid—Asthenia—Imiquimod—skin cancer	0.000577	0.00579	CcSEcCtD
Isoniazid—Nausea—Vemurafenib—skin cancer	0.00056	0.00562	CcSEcCtD
Isoniazid—Thrombocytopenia—Bleomycin—skin cancer	0.00056	0.00561	CcSEcCtD
Isoniazid—Discomfort—Dactinomycin—skin cancer	0.000549	0.00551	CcSEcCtD
Isoniazid—Ill-defined disorder—Temozolomide—skin cancer	0.000548	0.0055	CcSEcCtD
Isoniazid—Anorexia—Bleomycin—skin cancer	0.000545	0.00547	CcSEcCtD
Isoniazid—Malaise—Temozolomide—skin cancer	0.000533	0.00534	CcSEcCtD
Isoniazid—Thrombocytopenia—Dactinomycin—skin cancer	0.000522	0.00524	CcSEcCtD
Isoniazid—Paraesthesia—Bleomycin—skin cancer	0.000513	0.00515	CcSEcCtD
Isoniazid—Convulsion—Temozolomide—skin cancer	0.000512	0.00513	CcSEcCtD
Isoniazid—Vomiting—Imiquimod—skin cancer	0.000512	0.00513	CcSEcCtD
Isoniazid—Anorexia—Dactinomycin—skin cancer	0.000508	0.0051	CcSEcCtD
Isoniazid—Rash—Imiquimod—skin cancer	0.000507	0.00509	CcSEcCtD
Isoniazid—Discomfort—Temozolomide—skin cancer	0.000497	0.00499	CcSEcCtD
Isoniazid—Decreased appetite—Bleomycin—skin cancer	0.000497	0.00498	CcSEcCtD
Isoniazid—Neuropathy peripheral—Docetaxel—skin cancer	0.000493	0.00494	CcSEcCtD
Isoniazid—Jaundice—Docetaxel—skin cancer	0.00049	0.00492	CcSEcCtD
Isoniazid—Nausea—Imiquimod—skin cancer	0.000478	0.00479	CcSEcCtD
Isoniazid—Thrombocytopenia—Temozolomide—skin cancer	0.000472	0.00474	CcSEcCtD
Isoniazid—Convulsion—Fluorouracil—skin cancer	0.000472	0.00473	CcSEcCtD
Isoniazid—Feeling abnormal—Bleomycin—skin cancer	0.000471	0.00473	CcSEcCtD
Isoniazid—Agranulocytosis—Docetaxel—skin cancer	0.000469	0.00471	CcSEcCtD
Isoniazid—Decreased appetite—Dactinomycin—skin cancer	0.000463	0.00465	CcSEcCtD
Isoniazid—Fatigue—Dactinomycin—skin cancer	0.00046	0.00461	CcSEcCtD
Isoniazid—Anorexia—Temozolomide—skin cancer	0.00046	0.00461	CcSEcCtD
Isoniazid—Discomfort—Fluorouracil—skin cancer	0.000458	0.00459	CcSEcCtD
Isoniazid—Body temperature increased—Bleomycin—skin cancer	0.000452	0.00453	CcSEcCtD
Isoniazid—Hepatitis—Docetaxel—skin cancer	0.000451	0.00453	CcSEcCtD
Isoniazid—Feeling abnormal—Dactinomycin—skin cancer	0.000439	0.00441	CcSEcCtD
Isoniazid—Thrombocytopenia—Fluorouracil—skin cancer	0.000435	0.00436	CcSEcCtD
Isoniazid—Paraesthesia—Temozolomide—skin cancer	0.000433	0.00434	CcSEcCtD
Isoniazid—Dyspepsia—Temozolomide—skin cancer	0.000424	0.00426	CcSEcCtD
Isoniazid—Anorexia—Fluorouracil—skin cancer	0.000424	0.00425	CcSEcCtD
Isoniazid—Body temperature increased—Dactinomycin—skin cancer	0.000421	0.00423	CcSEcCtD
Isoniazid—Hypersensitivity—Bleomycin—skin cancer	0.000421	0.00422	CcSEcCtD
Isoniazid—Decreased appetite—Temozolomide—skin cancer	0.000419	0.0042	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Temozolomide—skin cancer	0.000416	0.00418	CcSEcCtD
Isoniazid—Fatigue—Temozolomide—skin cancer	0.000416	0.00417	CcSEcCtD
Isoniazid—Asthenia—Bleomycin—skin cancer	0.00041	0.00411	CcSEcCtD
Isoniazid—Paraesthesia—Fluorouracil—skin cancer	0.000399	0.004	CcSEcCtD
Isoniazid—Feeling abnormal—Temozolomide—skin cancer	0.000397	0.00399	CcSEcCtD
Isoniazid—Hypersensitivity—Dactinomycin—skin cancer	0.000393	0.00394	CcSEcCtD
Isoniazid—Dyspepsia—Fluorouracil—skin cancer	0.000391	0.00392	CcSEcCtD
Isoniazid—Decreased appetite—Fluorouracil—skin cancer	0.000386	0.00387	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000384	0.00385	CcSEcCtD
Isoniazid—Asthenia—Dactinomycin—skin cancer	0.000383	0.00384	CcSEcCtD
Isoniazid—Body temperature increased—Temozolomide—skin cancer	0.000381	0.00382	CcSEcCtD
Isoniazid—Feeling abnormal—Fluorouracil—skin cancer	0.000366	0.00367	CcSEcCtD
Isoniazid—Vomiting—Bleomycin—skin cancer	0.000363	0.00365	CcSEcCtD
Isoniazid—Rash—Bleomycin—skin cancer	0.00036	0.00362	CcSEcCtD
Isoniazid—Hypersensitivity—Temozolomide—skin cancer	0.000355	0.00356	CcSEcCtD
Isoniazid—Body temperature increased—Fluorouracil—skin cancer	0.000351	0.00352	CcSEcCtD
Isoniazid—Asthenia—Temozolomide—skin cancer	0.000346	0.00347	CcSEcCtD
Isoniazid—Convulsion—Docetaxel—skin cancer	0.00034	0.00341	CcSEcCtD
Isoniazid—Nausea—Bleomycin—skin cancer	0.00034	0.00341	CcSEcCtD
Isoniazid—Vomiting—Dactinomycin—skin cancer	0.000339	0.0034	CcSEcCtD
Isoniazid—Rash—Dactinomycin—skin cancer	0.000336	0.00337	CcSEcCtD
Isoniazid—Hypersensitivity—Fluorouracil—skin cancer	0.000327	0.00328	CcSEcCtD
Isoniazid—Nausea—Dactinomycin—skin cancer	0.000317	0.00318	CcSEcCtD
Isoniazid—Thrombocytopenia—Docetaxel—skin cancer	0.000314	0.00315	CcSEcCtD
Isoniazid—Vomiting—Temozolomide—skin cancer	0.000307	0.00308	CcSEcCtD
Isoniazid—Anorexia—Docetaxel—skin cancer	0.000306	0.00307	CcSEcCtD
Isoniazid—Rash—Temozolomide—skin cancer	0.000304	0.00305	CcSEcCtD
Isoniazid—Paraesthesia—Docetaxel—skin cancer	0.000288	0.00289	CcSEcCtD
Isoniazid—Nausea—Temozolomide—skin cancer	0.000286	0.00287	CcSEcCtD
Isoniazid—Vomiting—Fluorouracil—skin cancer	0.000282	0.00283	CcSEcCtD
Isoniazid—Dyspepsia—Docetaxel—skin cancer	0.000282	0.00283	CcSEcCtD
Isoniazid—Rash—Fluorouracil—skin cancer	0.00028	0.00281	CcSEcCtD
Isoniazid—Decreased appetite—Docetaxel—skin cancer	0.000279	0.0028	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Docetaxel—skin cancer	0.000277	0.00278	CcSEcCtD
Isoniazid—Fatigue—Docetaxel—skin cancer	0.000276	0.00277	CcSEcCtD
Isoniazid—Feeling abnormal—Docetaxel—skin cancer	0.000264	0.00265	CcSEcCtD
Isoniazid—Nausea—Fluorouracil—skin cancer	0.000264	0.00265	CcSEcCtD
Isoniazid—Body temperature increased—Docetaxel—skin cancer	0.000253	0.00254	CcSEcCtD
Isoniazid—Hypersensitivity—Docetaxel—skin cancer	0.000236	0.00237	CcSEcCtD
Isoniazid—Asthenia—Docetaxel—skin cancer	0.00023	0.00231	CcSEcCtD
Isoniazid—Vomiting—Docetaxel—skin cancer	0.000204	0.00205	CcSEcCtD
Isoniazid—Rash—Docetaxel—skin cancer	0.000202	0.00203	CcSEcCtD
Isoniazid—Nausea—Docetaxel—skin cancer	0.00019	0.00191	CcSEcCtD
